ResearcherInnsbruck Medical UniversityActive in the last 2 years
Ruben Bellotti
Matched on ORCID iD 0000-0002-9451-0794; OpenAlex author ID A5027603674. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 3 papers
Papers 6
- Patterns, timing and predictors of recurrence following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: an international multicentre retrospectiv… Co-author DOI 10.1016/j.hpb.2024.11.015↗
- Long-term Outcomes Following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) Versus Pancreatic Ductal Adenocarcinoma … Co-author DOI 10.1097/sla.0000000000006272↗
- Venous Resection During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma-A Multicentre Propensity Score Matching Analysis of the Recurrence After Whi… Co-author DOI 10.3390/cancers17071223↗
- Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After W… Co-author DOI 10.1016/j.hpb.2024.04.010↗
- Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. First author DOI 10.3390/curroncol29120773↗
- Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development. Co-author DOI 10.3390/cancers13143431↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Manuel Maglione · 3 shared papers, 2021–2025 · strength 0.47
- Paper Venous Resection During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma-A Multicentre Propensity Score Match… DOI 10.3390/cancers17071223↗
- Paper Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. DOI 10.3390/curroncol29120773↗
- Paper Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development. DOI 10.3390/cancers13143431↗
- Cornelia Speth · 2 shared papers, 2021–2022 · strength 0.30
- Duncan R.C. Spalding · 1 shared paper, 2025 · strength 0.16
- Alberto Porcu · 1 shared paper, 2025 · strength 0.16
- Thomas Brendon Russell · 1 shared paper, 2025 · strength 0.16
- Fabio Ausania · 1 shared paper, 2025 · strength 0.16
- Ricky Harminder Bhogal · 1 shared paper, 2025 · strength 0.16
- Somaiah Aroori · 1 shared paper, 2025 · strength 0.16
- Ismael Domínguez-Rosado · 1 shared paper, 2025 · strength 0.16
- Bilal A. Al-Sarireh · 1 shared paper, 2025 · strength 0.16
- Dhanny Gomez · 1 shared paper, 2025 · strength 0.16
- Brian Ritchie Davidson · 1 shared paper, 2025 · strength 0.16
- Keith John Roberts · 1 shared paper, 2025 · strength 0.16
- Peter Lawrence Zaki Labib · 1 shared paper, 2025 · strength 0.16
- Andrew Malvern Smith · 1 shared paper, 2025 · strength 0.16
- Zaed Z. R. Hamady · 1 shared paper, 2025 · strength 0.16
- Daniel Gerald Croagh · 1 shared paper, 2025 · strength 0.16
- Elizabeth Pando · 1 shared paper, 2025 · strength 0.16
- Adam Enver Frampton · 1 shared paper, 2025 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.